Opus Genetics Inc share price logo

Opus Genetics Inc Share Price

NASDAQ: IRD

Small Cap

$2.29

+0.32

(+15.99%)

as on

Opus Genetics Inc Stock Performance

as on November 1, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.96
    $2.3
    downward going graph

    14.41%

    Downside

    0.44%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.65
    $2.3
    downward going graph

    71.62%

    Downside

    0.56%

    Upside

    downward going graph

Opus Genetics Inc share price movements today

Previous Close
$1.97
Open
$2.02
Volume
1.7M
Day's Low - High
$1.96 - $2.3
52 Week Low - High
$0.65 - $2.3

Opus Genetics Inc Historical Returns

1 Month Return
+ 22.34 %
3 Month Return
+ 114.95 %
1 Year Return
+ 94.92 %
3 Year Return
0 %
5 Year Return
0 %

Opus Genetics Inc Stock Fundamentals & Key Indicators

Check Opus Genetics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$137.8M

EPS (TTM)

-0.6

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-200.57%

Opus Genetics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Opus Genetics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$137.8MNANA0.00%
BUY$40.4B478.23%-16.34-264.83%
BUY$60.2B253.38%1425.121.36%
BUY$109.1B101.56%30.3131.86%
BUY$68.5B16.98%15.6232.13%

Stock Returns calculator for Opus Genetics Inc Stock including INR - Dollar returns

The Opus Genetics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Opus Genetics Inc investment value today

Current value as on today

₹1,99,774

Returns

₹99,774

(+99.77%)

Returns from Opus Genetics Inc Stock

₹94,068 (+94.07%)

Dollar Returns*

₹5,706 (+5.71%)

Opus Genetics Inc Stock’s Investor Sentiment and Interest

Search interest for Opus Genetics Inc Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-19% versus previous 30 day period

Opus Genetics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
1
3
11
1
1
1
3
4
4
2
Gross Profit
1
3
11
1
1
1
3
4
4
-
Operating Income
-6
-5
6
-5
-7
-8
-8
-38
-9
-8
EBITDA
-6
-5
6
-4
-7
-8
-7
-35
-6
-8
Interest Expense
-
-
1
-
-
-
-
-
1
0
Depreciation
-
0
0
0
-
-
-
0
0
0
Income Before Tax
-5
-4
5
-4
-7
-7
-7
-35
-8
-7
Income Tax Expense
-
-
0
0
-
-
-
-
-
-
Net Income
-5
-4
5
-4
-7
-7
-7
-35
-8
-7
Net Profit Margin
-331.10%
-135.03%
46.59%
-283.56%
-415.31%
-698.29%
-194.62%
-816.71%
-187.51%
-257.46%

Opus Genetics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
0
39
19
10
Gross Profit
0
0
39
19
10
Operating Income
-19
-22
18
-10
-62
EBITDA
-17
-56
18
-9
-57
Interest Expense
6
0
0
1
-
Depreciation
0
0
0
0
0
Income Before Tax
-24
-56
18
-9
-57
Income Tax Expense
-
-
0
0
-
Net Income
-24
-56
17
-9
-57
Net Profit Margin
0.00%
-9625.30%
44.89%
-52.42%
-523.40%

Opus Genetics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-4
5
-4
-7
-7
-7
-35
-8
-7
Operating Cash Flow
0
-3
4
-5
-7
-5
-7
-8
-10
Investing Cash Flow
-
-
-
-
-
-
1
-
-
Financing Cash Flow
-
5
3
2
1
0
0
20
0
Change in Cash
0
2
8
-3
-5
-4
-6
11
-9

Opus Genetics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-24
-56
17
-9
-57
Operating Cash Flow
-6
-19
14
-1
-25
Investing Cash Flow
0
0
-
-
1
Financing Cash Flow
21
27
3
8
4
Change in Cash
14
8
18
7
-20

Insights on Opus Genetics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, IRD stock has moved up by 15.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 177.5% return, outperforming this stock by 82.6%

About Opus Genetics Inc

Opus Genetics, Inc. is a clinical-stage ophthalmic biotechnology company. The Company is engaged in developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other types of therapies for additional ophthalmic disorders. The Company’s pipeline includes adeno-associated virus (AAV)-based investigational gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. Its pipeline also includes OPGx-BEST1 investigational gene therapy, designed to address mutations in the BEST1 gene, which is associated with retinal degeneration. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist being investigated to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 being investigated to slow the progression of non-proliferative diabetic retinopathy.
OrganisationOpus Genetics Inc
Headquarters8 Davis Drive, Durham, NC, United States, 27709
CEOMr. George Magrath M.B.A., M.D., M.S.
E-voting on sharesClick here to vote

Key Management of Opus Genetics Inc

Name

Title

Dr. Benjamin R. Yerxa Ph.D.

President & Director

Dr. Ashwath Jayagopal Ph.D.

Chief Scientific & Development Officer

Mr. Robert E. Gagnon

CFO & Principal Accounting Officer

Mr. Joseph K. Schachle MBA

Chief Operating Officer

Ms. Sally Tucker

Senior Vice President of Clinical Development

Mr. Erik Sims

Director & Corporate Controller

Mr. George Magrath M.B.A., M.D., M.S.

CEO & Director

Ms. Jenny Kobin

Investor Relations Officer

Mr. Bernhard Hoffmann M.B.A.

Senior Vice President of Corporate Development & Secretary

Ms. Bindu Manne

Head of Market Development & Commercialization

FAQs

What is Opus Genetics Inc share price today?

Opus Genetics Inc share price today is $2.29 as on at the close of the market. Opus Genetics Inc share today touched a day high of $2.3 and a low of $1.96.

What is the 52 week high and 52 week low for Opus Genetics Inc share?

Opus Genetics Inc share touched a 52 week high of $2.3 on and a 52 week low of $0.65 on . Opus Genetics Inc stock price today i.e. is closed at $2.29,which is 0.56% down from its 52 week high and 252.31% up from its 52 week low.

What is Opus Genetics Inc's market capitalisation today?

Opus Genetics Inc market capitalisation is $0.00T as on .

How to invest in Opus Genetics Inc Stock (IRD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Opus Genetics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Opus Genetics Inc Shares that will get you 0.6550 shares as per Opus Genetics Inc share price of $2.29 per share as on November 1, 2025 at 1:29 am IST.

What is the minimum amount required to buy Opus Genetics Inc Stock (IRD) from India?

Indian investors can start investing in Opus Genetics Inc (IRD) shares with as little as ₹88.719 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.19 in Opus Genetics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Opus Genetics Inc share’s latest price of $2.29 as on November 1, 2025 at 1:29 am IST, you will get 4.3668 shares of Opus Genetics Inc. Learn more about fractional shares .